TITLE

SECRETIN MRCP DERIVED FUNCTION IN CHRONIC PANCREATITIS

AUTHOR(S)
Gillams, A.; Pereira, S.; Lees, W.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: We have previously reported the use of secretin MRCP to quantify pancreatic function. We have now studied a group of normal patients and patients with chronic pancreatitis. Methods: 62 patients referred with suspected or known pancreatic pathology underwent SSFSE MRCP both before and after O. 1 mi/kg IV secretin. The sequence with identical positioning and receiver gain was performed prior to secretin and at 2 min intervals post-secretin to a mean of 7 min. All patients also underwent parenchymal pancreatic imaging with a coronal trufisp and axial T1W sequence. The pancreatic flow rate was calculated as the change in signal intensity over time within a ROI that encompassed not only the pancreas but the small bowel. A voxel containing 100% water was used to correct for variations in receiver gain between individuals. 63 patients had concurrent CT scans. Using the Cambridge classification patients were divided into mild, moderate, and severe chronic pancreatitis. Results: There were 31 patients with a normal pancreas. The mean flow rate was 8.0 ml/min +/- 2.6. 31 patients had evidence of chronic pancreatitis, 6 mild, 6 moderate, and 19 severe chronic pancreatitis. The mean flow rates were; mild pancreatitis 6.9 +/- 1.7, moderate 6.0 +/- 1.7, and severe 5.9 +/- 2.9. This was statistically significant from the normal group. Conclusion: Significantly different flow rates were found in patients with severe chronic pancreatitis compared with normals. Further, there appeared to be trend down through the different levels of severity of chronic pancreatitis. Changes in flow rates in a given individual should provide useful information and a trend down on sequential measurements may prove to be an early indicator for pancreatic disease.
ACCESSION #
9747381

 

Related Articles

  • PANCREAS DIVISUM--ANOTHER DIAGNOSTIC TEST? Cunningham, John T.; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Mar1992, Vol. 87 Issue 3, p400 

    Presents an abstract of the study "Dynamic CT Scanning of Pancreatic Duct After Secretin Provocation in Pancreas Divisum," by E. Lindstrom and I. Ihse, published in a 1990 issue of the journal "Digestive Diseases Science."

  • Evaluation of the stimulating effect of a low dose of secretin compared to the standard dose on the exocrine pancreas with MRCP: preliminary results in normal subjects (MRCP quantification of secretin stimulation). Bali, Maria; Sontou, Regis; Arvanitakis, Marianna; Metens, Thierry; Devière, Jacques; Matos, Celso // Abdominal Imaging;Nov2007, Vol. 32 Issue 6, p743 

    Secretin administration during MRCP improves depiction of pancreatic ducts and allows assessment of pancreatic exocrine secretions. However, secretin increases the cost of secretin-enhanced MRCP (S-MRCP). The aim of this study was to quantify using MRCP the stimulating effect of 0.3 CU/kg of...

  • THE SONOGRAPHIC SECRETIN TEST IN PANCREATIC DISEASE -- HERE OR HISTORY? Pletcher, Steven D.; Lehman, Glen; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Aug1990, Vol. 85 Issue 8, p1041 

    The pancreatic duct was studied prospectively with secretin-stimulated ultrasonography in 59 patients with possible pancreatic disease and 20 healthy controls. Patients with acute pancreatitis, biliary obstruction, known pancreatic duct occlusion, or pancreatic duct >4 mm by sonography were...

  • Anatomic variants of the pancreatic duct and their clinical relevance: an MR-guided study in the general population. Bülow, Robin; Simon, Peter; Thiel, Robert; Thamm, Patrick; Messner, Philip; Lerch, Markus; Mayerle, Julia; Völzke, Henry; Hosten, Norbert; Kühn, Jens-Peter // European Radiology;Dec2014, Vol. 24 Issue 12, p3142 

    Objectives: To investigate the frequency of pancreatic duct (PD) variants and their effect on pancreatic exocrine function in a population-based study using non-invasive secretin-stimulated magnetic resonance cholangiopancreatography (sMRCP). Methods: Nine hundred and ninety-five volunteers, 457...

  • Does secretin add value in pediatric magnetic resonance cholangiopancreatography? Trout, Andrew; Podberesky, Daniel; Serai, Suraj; Ren, Yan; Altaye, Mekebib; Towbin, Alexander // Pediatric Radiology;Apr2013, Vol. 43 Issue 4, p479 

    Background: Secretin-a hormone that stimulates pancreatic exocrine secretion-is described to improve visualization of the pancreatic duct by magnetic resonance cholangiopancreatography (MRCP). In our pediatric practice, however, we have not observed substantial benefit with the use of secretin....

  • The Hypersecretory States of the Pancreas. Dreiling, David A.; Greenstein, Adrian J.; Bordalo, Orlando // American Journal of Gastroenterology;Jun1973, Vol. 59 Issue 6, p505 

    Analyzes the pancreatic secretory data of patients with pancreatic hypersecretion, including cirrhosis, hemachromatosis and Zollinger-Ellison syndrome. Pancreatic flows and bicarbonate secretory responses to secretin; Secretin response before and after prolonged reversed pancreatic duct...

  • Magnetic resonance imaging for diagnosing chronic pancreatitis. Sugiyama, Masanori; Haradome, Hiroki; Atomi, Yutaka // Journal of Gastroenterology;Jan2007 Supplement 17, Vol. 42, p108 

    Endoscopic retrograde cholangiopancreatography (ERCP) is highly sensitive for detecting chronic pancreatitis, even when mild, but it is invasive. Magnetic resonance cholangiopancreatography (MRCP), a noninvasive modality, well demonstrates dilatation, stricture, and irregularity of the main...

  • Diagnosis of early-stage chronic pancreatitis by secretin-enhanced magnetic resonance cholangiopancreatography. Czakó, László // Journal of Gastroenterology;Jan2007 Supplement 17, Vol. 42, p113 

    A diagnostic means of detecting chronic pancreatitis at an early stage, when the disease is still reversible, needs to be developed. Magnetic resonance cholangiopancreatography (MRCP) has recently been evolving as an important tool for the evaluation of chronic pancreatitis. In patients with...

  • Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis. Initial results. Bali, M. A.; Sztantics, A.; Metens, T.; Arvanitakis, M.; Delhaye, M.; Devière, J.; Matos, C. // European Radiology;Oct2005, Vol. 15 Issue 10, p2110 

    The aim of this study was to quantify pancreatic exocrine function in normal subjects and in patients with chronic pancreatitis (CP) before and after pancreatic duct drainage procedures (PDDP) with dynamic secretin-enhanced magnetic resonance (MR) cholangiopancreatography (S-MRCP). Pancreatic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics